Jason Napodano
Jason Napodano
Stop FollowingJason Napodano
ABOUT
I am a professional sell-side equity research analyst. I currently work for Zacks Investment Research. I started my career with Zacks covering the large-cap Pharma sector in 2003. In 2009, I was promoted to Managing Director of Institutional Equity Research. I now focus on small-cap biotech for Zacks.
Prior to Zacks, I spent 3 years on the buy-side with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology.
Prior to Joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases. I also spent a year working in a lab at the Fralin ...More Biotechnology Center, and a year working for a cancer researcher in Virginia.
I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I am a Chartered Financial Analyst (CFA)
Prior to Zacks, I spent 3 years on the buy-side with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology.
Prior to Joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases. I also spent a year working in a lab at the Fralin ...More Biotechnology Center, and a year working for a cancer researcher in Virginia.
I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I am a Chartered Financial Analyst (CFA)
SNAPSHOT
- Description: Sell side analyst. Trading frequency: Infrequent
- Interests: Stocks - long
COMPANY
BLOG
Latest Comments
more »
- There is no device on the m... on LabStyle Innovations - Glucose Monitoring For T...
- LabStyle plans to charge ar... on LabStyle Innovations - Glucose Monitoring For T...
- The original document state... on LabStyle Innovations - Glucose Monitoring For T...
- I dont know of anyone off h... on LabStyle Innovations - Glucose Monitoring For T...
- You are truly passionate ab... on Does Cell Therapy Hold The Key To Treating Stroke?
Latest comments on Jason's Articles
- Edward Yoxen on LabStyle Innovations - Glucose Monitoring For T...
- dad58 on Amarantus' LymPro Could Be A Game-Changer For A...
- freewillybird on LabStyle Innovations - Glucose Monitoring For T...
- FatherLucifer on LabStyle Innovations - Glucose Monitoring For T...
- Jim Brody on LabStyle Innovations - Glucose Monitoring For T...
LATEST ARTICLES & INSTAPOSTS
more »



